Acura Pharmaceuticals, Inc. Secures Bridge Funding
16 août 2006 16h04 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Aug. 16, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $450,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Announces 2nd Quarter 2006 Financial Results and OxyADF Tablet Development Status
27 juil. 2006 16h05 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., July 27, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $2.6 million or $0.01 per share for the quarter ending June 30, 2006 compared to a...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
30 juin 2006 17h23 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., June 30, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $335,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
24 mai 2006 16h01 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., May 24, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $800,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Announces Appointment of Richard Markham as Director
15 mai 2006 16h00 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., May 15, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) is pleased to announce the appointment of Richard J. Markham to its Board of Directors.
Mr. Markham brings to...
Acura Pharmaceuticals, Inc. Announces First Quarter 2006 Results
26 avr. 2006 16h01 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., April 26, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $4.2 million or $0.01 per share for the quarter ending March 31, 2006, compared to...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
27 mars 2006 17h32 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., March 27, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $750,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Reports 2005 Financial Results, and Updates OxyADF Tablet Development, Commercial Strategy and Cash Reserves
21 févr. 2006 16h01 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Feb. 21, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $7.1 million or $0.04 per share for the quarter ending December 31, 2005 compared to...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
31 janv. 2006 16h01 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Jan. 31, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $750,000 under a term loan agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Reports Financial Results for Q3-05, Bridge Funding, Conversion of Preferred Shares, Update on OxyADF Development and Cash Reserves
10 nov. 2005 16h01 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Nov. 10, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $1.6 million or $0.07 per share for the quarter ended September 30, 2005 compared...